Loading clinical trials...
Loading clinical trials...
In the POELH-II trial (Clinicaltrials.gov ID NCT05678218) patients with presumed resectable perihilar (pCCA), intrahepatic (iCCA) or mid-common bile duct (CBD) cholangiocarcinoma had the outcomes of t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Erasmus Medical Center
NCT06840886 · Advanced Solid Tumors, Ovarian Cancer, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT05546372 · Perihilar Cholangiocarcinoma
NCT06058663 · Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, and more
NCT06728410 · Intrahepatic Cholangiocarcinoma, FGFR2 Gene Rearrangement, and more
Erasmus MC University Medical Center
Rotterdam, South Holland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions